NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Follow-Up Questions
NovaBay Pharmaceuticals Inc 的 CEO 是谁？
Mr. Justin Hall 是 NovaBay Pharmaceuticals Inc 的 Chief Executive Officer，自 2015 加入公司。
NBY 股票的价格表现如何？
NBY 的当前价格为 $1.88，在上个交易日 increased 了 3.8%。
NovaBay Pharmaceuticals Inc 的主要业务主题或行业是什么？
NovaBay Pharmaceuticals Inc 属于 Pharmaceuticals 行业，该板块是 Health Care
